This article was originally published in The Gray Sheet
Planned closure of the firm's Ronneby, Sweden and Miami Lakes, Florida plants, which made recently discontinued A-series hemodialyzer components, is announced Nov. 26. The Swedish filter plant and the Florida filter fiber facility employed 158 and 98 people, respectively. A small team will remain at both locations to continue ongoing investigations into more than 50 deaths worldwide that appear linked to a processing fluid residue ("The Gray Sheet" Nov. 12, 2001, p. 16). Baxter has agreed to pay the families of 10 fatalities in Spain $289,000 each under a settlement agreement; the families are asking the Spanish government to drop a planned lawsuit. A Swedish criminal investigation is ongoing...
You may also be interested in...
Recent patient safety-related measures taken by Baxter International may help improve the firm's public image after a series of recalls and warning letters related to Baxter dialyzers and infusion pumps
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.